Sells virtual care for chronic conditions and physical therapy to employers, health plans, and health systems.
10-K for FY2025, filed Mar 6, 2026Our mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what…View ↗
We launched our first program focused on diabetes prevention in 2012. Since then, we also observed a demand from our customers and channel…View ↗
Launched by Omada in 2020, Omada for MSK connects individuals to licensed physical therapists for consultation and virtual treatment for…View ↗
For virtual care, customers pay fees based on member enrollment and/or engagement; hardware sales are counted when devices ship.
10-K for FY2025, filed Mar 6, 2026
FY2025 revenue by product or service ↗$260.2M
10-K for FY2025, filed Mar 6, 2026
$260.2M ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Services
Usage-based
10-K for FY2025, filed Mar 6, 2026 |
93% |
Services, FY2025
$241M Sources
|
Usage-based |
|
Hardware
Sold outright
|
7.4% |
Hardware, FY2025
$19.2M Sources
|
Sold outright |
Employers and healthcare organizations cover programs for employees or patients. Omada sells directly to customers and through channel partners, including health plans and pharmacy benefit managers that resell programs to end customers.
10-K for FY2025, filed Mar 6, 2026Our mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what…View ↗
Since our founding, our programs have had a meaningful, positive impact. As of December 31, 2025, we had more than 2,000 customers, over…View ↗
Our go-to-market strategy follows a business-to-business-to-consumer motion. We contract with a wide variety of customers and channel…View ↗
We sell our programs directly to customers and through channel partners. Our sales and account management teams are structured to reflect…View ↗
Not on paper. It lost $12.8M in FY2025, but brought in more cash than it spent: $16.9M of free cash flow.
10-K for FY2025, filed Mar 6, 2026
−$12MView ↗
10-K for FY2025, filed Mar 6, 2026
−$12.8MView ↗
10-K for FY2025, filed Mar 6, 2026
$16.9MView ↗
10-Q for Q2 FY2026, filed Aug 7, 2026
$5.3MView ↗
10-Q for Q2 FY2026, filed Aug 7, 2026
Open tableView ↗
8-K, filed Aug 6, 2026
Revenue in the range of $334 million to $340 million, with the midpoint representing 30% growth compared with 2025; this range is up from…View ↗
Competes with Hello Heart, Lark Technologies, Livongo, Teladoc Health, Onduo, Vida Health, Virta Health, Hinge Health, SWORD Health, and DarioHealth
10-K for FY2025, filed Mar 6, 2026While our market is in an early stage of development, it is evolving rapidly and becoming increasingly competitive. We currently face…View ↗
Loading...